ANIP

ANI PHARMACEUTICALS INC

ANIP·00182C103·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist

ANIP (ANI PHARMACEUTICALS INC) is held by 156 institutional investors as of Q2 2026. Largest holders: BlackRock, Inc. ($244.9M), VANGUARD CAPITAL MANAGEMENT LLC ($69.4M), STATE STREET CORP ($68.9M). Net institutional sentiment: Mixed.

156
Holders
(10 Elite)
$1.4B
Total Value
57% (148)
Consensus
84 buying - 64 selling
13F: Insider & Congress: Updated regularly
ANIP

Smart Money Verdict

View all
Loading verdict
Held by 156 funds
10 elite

Who's Trading

Source dates: Price Oct 14, 2026 · Insiders Oct 13, 2026 · Activists Jul 27, 2026 · Congress none

InsiderCMCook MeredithSell $37KOct 13, 2026
InsiderCPCAREY STEPHEN P.Sell $208KSep 29, 2026
InsiderLNLalwani NikhilSell $383KSep 15, 2026
Checking access…

Top Holders

Checking access…
Action
Increased
3M(+7.7%)$244.9M0.0%+19.38%
33
Increased
838,224(+1.8%)$69.4M0.0%-8.89%
30
Increased
831,647(+7.8%)$68.9M0.0%+14.60%
32
Increased
623,463(+17.4%)$51.6M0.0%+11.05%
34
Increased
574,474(+199.9%)$47.6M0.0%-13.16%
47
Decreased
562,016(-0.4%)$46.5M0.0%-19.07%
0
Increased
536,407(+9.7%)$44.4M0.0%+22.10%
32
Decreased
507,207(-14.3%)$42M0.0%-8.44%
0
Increased
415,024(+3.1%)$34.4M0.0%+3.32%
30
Increased
407,281(+8.3%)$33.7M0.0%-9.30%
31
Increased
323,443(+1.2%)$26.8M0.0%+1.49%
29
Decreased
309,233(-4.7%)$25.6M0.0%+1.31%
0
Decreased
297,539(-40.2%)$24.6M0.0%-6.20%
0
Increased
287,382(+6.3%)$23.8M0.0%+39.08%
30
Decreased
287,206(-0.1%)$23.8M0.0%-11.12%
0
Increased
271,760(+31.8%)$22.5M0.0%+6.71%
36
Decreased
258,173(-21.1%)$21.4M0.1%+82.66%
0
Increased
252,574(+7.8%)$20.9M0.0%+12.58%
31
Increased
232,954(+5.8%)$19.7M0.0%-1.00%
30
Decreased
233,955(-1.4%)$19.4M0.0%-15.86%
0

Showing 1-20 of 160

1 / 8
ANIPANIPANI PHARMACEUTICALS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used